Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen V Faraone

Showing results (1-10 of 958) with videos related to

Pageof 96
Sort By:
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 5, 2003
Report from the 4th international meeting of the attention deficit hyperactivity disorder molecular genetics networkStephen V Faraone
Biological Psychiatry|August 29, 2020
The Impact of Attention-Deficit/Hyperactivity Disorder Medications on Suicidality: Implications and MechanismsStephen V Faraone
Journal of the American Academy of Child and Adolescent Psychiatry|October 1, 2013
Real progress in molecular psychiatric geneticsStephen V Faraone
Prevention Science : the Official Journal of the Society for Prevention Research|March 21, 2024
Understanding Environmental Exposures and ADHD: a Pathway ForwardStephen V Faraone
Journal of Attention Disorders|September 15, 2010
Understanding the effect size of lisdexamfetamine dimesylate for treating ADHD in children and adultsStephen V Faraone
P & T : a Peer-Reviewed Journal for Formulary Management|September 15, 2009
Interpreting estimates of treatment effects: implications for managed careStephen V Faraone
Neuroscience and Biobehavioral Reviews|February 12, 2018
The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbiditiesStephen V Faraone
Lancet (London, England)|March 2, 2015
Attention deficit hyperactivity disorder and premature deathStephen V Faraone
The Psychiatric Clinics of North America|April 6, 2004
Genetics of adult attention-deficit/hyperactivity disorderStephen V Faraone
Expert Opinion on Pharmacotherapy|June 4, 2008
Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorderStephen V Faraone
Pageof 96

Showing results (1-10 of 958) with videos related to

Sort By:
Pageof 96
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 5, 2003
Report from the 4th international meeting of the attention deficit hyperactivity disorder molecular genetics networkStephen V Faraone
Biological Psychiatry|August 29, 2020
The Impact of Attention-Deficit/Hyperactivity Disorder Medications on Suicidality: Implications and MechanismsStephen V Faraone
Journal of the American Academy of Child and Adolescent Psychiatry|October 1, 2013
Real progress in molecular psychiatric geneticsStephen V Faraone
Prevention Science : the Official Journal of the Society for Prevention Research|March 21, 2024
Understanding Environmental Exposures and ADHD: a Pathway ForwardStephen V Faraone
Journal of Attention Disorders|September 15, 2010
Understanding the effect size of lisdexamfetamine dimesylate for treating ADHD in children and adultsStephen V Faraone
P & T : a Peer-Reviewed Journal for Formulary Management|September 15, 2009
Interpreting estimates of treatment effects: implications for managed careStephen V Faraone
Neuroscience and Biobehavioral Reviews|February 12, 2018
The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbiditiesStephen V Faraone
Lancet (London, England)|March 2, 2015
Attention deficit hyperactivity disorder and premature deathStephen V Faraone
The Psychiatric Clinics of North America|April 6, 2004
Genetics of adult attention-deficit/hyperactivity disorderStephen V Faraone
Expert Opinion on Pharmacotherapy|June 4, 2008
Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorderStephen V Faraone
Pageof 96